406 related articles for article (PubMed ID: 32835305)
1. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.
Sharma A; Garcia G; Wang Y; Plummer JT; Morizono K; Arumugaswami V; Svendsen CN
Cell Rep Med; 2020 Jul; 1(4):100052. PubMed ID: 32835305
[TBL] [Abstract][Full Text] [Related]
2. Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection.
Sharma A; Garcia G; Arumugaswami V; Svendsen CN
bioRxiv; 2020 Apr; ():. PubMed ID: 32511402
[TBL] [Abstract][Full Text] [Related]
3. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
[TBL] [Abstract][Full Text] [Related]
4. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.
Wong CK; Luk HK; Lai WH; Lau YM; Zhang RR; Wong AC; Lo GC; Chan KH; Hung IF; Tse HF; Woo PC; Lau SK; Siu CW
Circ J; 2020 Oct; 84(11):2027-2031. PubMed ID: 32981925
[TBL] [Abstract][Full Text] [Related]
5. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC
Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077
[TBL] [Abstract][Full Text] [Related]
6. Detection of Viral RNA Fragments in Human iPSC-Cardiomyocytes following Treatment with Extracellular Vesicles from SARS-CoV-2 Coding-Sequence-Overexpressing Lung Epithelial Cells.
Kwon Y; Nukala SB; Srivastava S; Miyamoto H; Ismail NI; Rehman J; Ong SB; Lee WH; Ong SG
bioRxiv; 2020 Jul; ():. PubMed ID: 32637965
[TBL] [Abstract][Full Text] [Related]
7. Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.
Kwon Y; Nukala SB; Srivastava S; Miyamoto H; Ismail NI; Jousma J; Rehman J; Ong SB; Lee WH; Ong SG
Stem Cell Res Ther; 2020 Nov; 11(1):514. PubMed ID: 33256833
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey E; Cohen NA; Weiss SR
bioRxiv; 2020 Nov; ():. PubMed ID: 32995797
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
He DD; Zhang XK; Zhu XY; Huang FF; Wang Z; Tu JC
Comput Biol Med; 2021 Apr; 131():104293. PubMed ID: 33662681
[TBL] [Abstract][Full Text] [Related]
10. Functional Effects of Cardiomyocyte Injury in COVID-19.
Siddiq MM; Chan AT; Miorin L; Yadaw AS; Beaumont KG; Kehrer T; Cupic A; White KM; Tolentino RE; Hu B; Stern AD; Tavassoly I; Hansen J; Sebra R; Martinez P; Prabha S; Dubois N; Schaniel C; Iyengar-Kapuganti R; Kukar N; Giustino G; Sud K; Nirenberg S; Kovatch P; Albrecht RA; Goldfarb J; Croft L; McLaughlin MA; Argulian E; Lerakis S; Narula J; García-Sastre A; Iyengar R
J Virol; 2022 Jan; 96(2):e0106321. PubMed ID: 34669512
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes.
Linn AK; Manopwisedjaroen S; Kanjanasirirat P; Borwornpinyo S; Hongeng S; Phanthong P; Thitithanyanont A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338708
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function.
Marchiano S; Hsiang TY; Khanna A; Higashi T; Whitmore LS; Bargehr J; Davaapil H; Chang J; Smith E; Ong LP; Colzani M; Reinecke H; Yang X; Pabon L; Sinha S; Najafian B; Sniadecki NJ; Bertero A; Gale M; Murry CE
Stem Cell Reports; 2021 Mar; 16(3):478-492. PubMed ID: 33657418
[TBL] [Abstract][Full Text] [Related]
13. BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes.
Kalejaiye TD; Bhattacharya R; Burt MA; Travieso T; Okafor AE; Mou X; Blasi M; Musah S
bioRxiv; 2021 Nov; ():. PubMed ID: 34816259
[TBL] [Abstract][Full Text] [Related]
14. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril.
Huang X; Fan W; Sun J; Yang J; Zhang Y; Wang Q; Li P; Zhang Y; Zhang S; Li H; Wang J; Feng L; Zhao J; Chen L; Qu L
Antiviral Res; 2023 Jul; 215():105636. PubMed ID: 37207821
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes.
Liu J; Wu S; Zhang Y; Wang C; Liu S; Wan J; Yang L
Stem Cell Res Ther; 2023 Sep; 14(1):249. PubMed ID: 37705046
[TBL] [Abstract][Full Text] [Related]
17. WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2.
Aragão LGHS; Oliveira JT; Temerozo JR; Mendes MA; Salerno JA; Pedrosa CSG; Puig-Pijuan T; Veríssimo CP; Ornelas IM; Torquato T; Vitória G; Sacramento CQ; Fintelman-Rodrigues N; da Silva Gomes Dias S; Cardoso Soares V; Souza LRQ; Karmirian K; Goto-Silva L; Biagi D; Cruvinel EM; Dariolli R; Furtado DR; Bozza PT; Borges HL; Souza TML; Guimarães MZP; Rehen SK
PeerJ; 2021; 9():e12262. PubMed ID: 34707939
[TBL] [Abstract][Full Text] [Related]
18. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.
Wicik Z; Eyileten C; Jakubik D; Simões SN; Martins DC; Pavão R; Siller-Matula JM; Postula M
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233425
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19.
Clemens DJ; Ye D; Zhou W; Kim CSJ; Pease DR; Navaratnarajah CK; Barkhymer A; Tester DJ; Nelson TJ; Cattaneo R; Schneider JW; Ackerman MJ
PLoS One; 2023; 18(3):e0282151. PubMed ID: 36888581
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection.
Liu X; Lou L; Zhou L
Front Cardiovasc Med; 2021; 8():643958. PubMed ID: 35127841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
